HYDROXYSTEROID DEHYDROGENASES IN THE HUMAN ADRENAL CORTEX

1966 ◽  
Vol 34 (4) ◽  
pp. 439-NP ◽  
Author(s):  
K. C. CALMAN ◽  
A. H. BAILLIE ◽  
M. M. FERGUSON ◽  
D. McK. HART

SUMMARY The histochemical utilization of 3α-, 3β-, 6β-, 11α-, 11β-, 12α-, 16α-, 16β-, 17α-, 17β-, 20α-, 21- and 24-hydroxysteroids by three normal adult human adrenal glands, two human foetal adrenal glands, three adrenals from patients with Cushing's syndrome and one adrenal adenoma are described. The normal adult human adrenal showed high 16β-hydroxysteroid dehydrogenase activity in the zona glomerulosa. Activity restricted to the outer part of the zona fasciculata was recorded with 3α-, 3β-, 6β-, 11β-, 16α-, 16β-, and 17β-hydroxysteroids. The zona reticularis utilized 3α-, 3β-, 11β-, 16β- and 17β-hydroxysteroids less well than the zona fasciculata. The adrenals of Cushing's syndrome showed activity only for 3β- and 16β-hydroxysteroid dehydrogenases; this activity was noted in all three zones. The activity pattern of the adrenal adenoma resembled that of the normal adult human adrenal except that greater activity for 16α-hydroxysteroid dehydrogenase was noted. The foetal part of the human foetal cortex was extremely active, showing 3α-, 3β-, 6β-, 11β-, 12α-, 16α-, 16β-, 17β-, 20β- and 21-hydroxysteroid dehydrogenase activity. The definitive cortex behaved similarly to the adult gland and possessed 3α-, 3β-, 11β-, 16β- and 17β-hydroxysteroid dehydrogenases; some evidence of zoning of the definitive cortex was seen with the 16β-hydroxysteroid. The relevance of these findings in the light of current knowledge of adrenal zonation is discussed.

1965 ◽  
Vol 31 (3) ◽  
pp. 227-NP ◽  
Author(s):  
A. H. BAILLIE ◽  
E. H. D. CAMERON ◽  
K. GRIFFITHS ◽  
D. McK. HART

SUMMARY 3β-Hydroxysteroid dehydrogenase activity was studied histochemically in human, monkey, and rat adrenal glands and in human placentae. Tissue sections were incubated separately with each of the following substrates: (1) 3β-hydroxypregn-5-en-20-one (pregnenolone); (2) sodium 3β-sulphoxypregn-5-en-20-one (pregnenolonesulphate); (3) 3β-acetoxypregn-5-en-20 one (pregnenoloneacetate); (4) 3β,16α-dihydroxypregn-5-en-20-one (16α-hydroxypregnenolone); (5) 3β,17α-dihydroxypregn-5-en-20-one (17α-hydroxypregnenolone); (6) ammonium 3β-sulphoxy-17α-hydroxypregn-5-en-20-one (17α-hydroxypregnenolone ammonium sulphate); (7) 3β-hydroxyandrost-5-en-17-one (DHA); (8) 3β-sulphoxyandrost-5-en-17-one (DHA sulphate); (9) 3β-acetoxyandrost-5-en-17-one (DHA acetate); (10) androst-5-ene-3β, 17β-diol (androstenediol). The histochemical results obtained with pregnenolone and DHA as substrates resemble those described by other workers. Using pregnenolone sulphate and 17α-hydroxypregnenolone sulphate, a strong histochemical reaction with diformazan deposition was found in the zona fasciculata of the adrenals of all species and in the placental syntrophoblast. With DHA sulphate an extremely weak histochemical reaction was obtained with the adrenal zona fasciculata, monoformazan only being deposited. The syntrophoblast, however, showed intense 3β-hydroxysteroid dehydrogenase activity when incubated with DHA sulphate. These results accord with recent findings regarding the secretion and metabolism of 3β-sulphoxysteroids. A strong histochemical reaction was also obtained in both adrenal and placental tissues using 17α-hydroxypregnenolone, 16α-hydroxypregnenolone, androstenediol, pregnenolone acetate, and DHA acetate. These steroids have not previously been described as substrates for the histochemical demonstration of 3β-hydroxysteroid dehydrogenase in the adrenal or placenta.


2008 ◽  
Vol 55 (4) ◽  
pp. 709-715 ◽  
Author(s):  
Hiroshi ARAI ◽  
Nozomi KOBAYASHI ◽  
Yuko NAKATSURU ◽  
Hiroaki MASUZAKI ◽  
Takuo NAMBU ◽  
...  

2017 ◽  
Author(s):  
Toshiro Seki ◽  
Atsushi Yasuda ◽  
Natsumi Kitajima ◽  
Masami Seki ◽  
Masayuki Oki ◽  
...  

2002 ◽  
Vol 50 (2) ◽  
pp. 133-142 ◽  
Author(s):  
Marina Tišljar ◽  
D. Janić ◽  
Ž. Grabarević ◽  

One of the most serious problems in the chinchilla industry is 'fur-chewing', when the chinchilla bites off areas of its own or some other animal's fur. The condition generally develops in both genders at the age of 6-8 months. In chinchilla farms in Croatia an incidence of 15-20% has been observed. A pathomorphological, microbiological and parasitological investigation was conducted on eleven 6- to 11-month-old chinchillas of both sexes with clinical symptoms of 'fur-chewing' and three chinchillas without such signs. Histopathology of the adrenal glands and of the chewed skin revealed changes typical of Cushing's syndrome in 'fur-chewed' chinchillas, such as hyperkeratinisation of the epidermis, epidermal atrophy, pronounced follicular and sebaceous gland atrophy, hyperkeratinisation of the follicles with comedo formations and the presence of calcium salts in subcutis.


2015 ◽  
Vol 62 (9) ◽  
pp. 466-469
Author(s):  
Run Yu ◽  
Meng Wei ◽  
Xuemo Fan ◽  
Richard R. Ellis ◽  
Glenn D. Braunstein

Life Sciences ◽  
1999 ◽  
Vol 65 (26) ◽  
pp. 2823-2827 ◽  
Author(s):  
Cinzia Tortorella ◽  
Francesco Aragona ◽  
Gastone G. Nussdorfer

2020 ◽  
Vol 4 (1) ◽  
pp. 56-58
Author(s):  
Shoko Uketa ◽  
Yousuke Shimizu ◽  
Kosuke Ogawa ◽  
Noriaki Utsunomiya ◽  
Satsuki Asai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document